Javascript must be enabled to continue!
Experiences about no-reflow in percutaneous transluminal coronary intervention of acute coronary syndrome
View through CrossRef
Aim
To analyse the causes and treatments of no-reflow in percutaneous transluminal coronary intervention of acute coronary syndrome patients.
Methods
Reviewed 68 patients of acute coronary syndrome who undergo percutaneous transluminal coronary intervention during June 2008 to July 2010 in our hospital. The possible reasons, the treatment outcome of immediately or discharged time were observed.
Results
In all 68 patients, no-reflow was occurred in six cases. One case was dead of carcinogenic shock at the time of 24 h post therapy,. The symptoms as chest distress and chest pain were improved and coronary flow was improved from TIMI 1 flow to TIMI 3 flow after nitroglycerin, verapamil and tirofiban Intracoronary injection alone or in combination. And there was no cardiovascular events occurred until discharged time in those five cases.
Conclusion
In percutaneous transluminal coronary intervention, no-reflow phenomenon increased risk of operation and mortality. Enhance the knowledge of no-reflow and coped with it timely in right way should improved coronary flow and prognosis of patients.
Title: Experiences about no-reflow in percutaneous transluminal coronary intervention of acute coronary syndrome
Description:
Aim
To analyse the causes and treatments of no-reflow in percutaneous transluminal coronary intervention of acute coronary syndrome patients.
Methods
Reviewed 68 patients of acute coronary syndrome who undergo percutaneous transluminal coronary intervention during June 2008 to July 2010 in our hospital.
The possible reasons, the treatment outcome of immediately or discharged time were observed.
Results
In all 68 patients, no-reflow was occurred in six cases.
One case was dead of carcinogenic shock at the time of 24 h post therapy,.
The symptoms as chest distress and chest pain were improved and coronary flow was improved from TIMI 1 flow to TIMI 3 flow after nitroglycerin, verapamil and tirofiban Intracoronary injection alone or in combination.
And there was no cardiovascular events occurred until discharged time in those five cases.
Conclusion
In percutaneous transluminal coronary intervention, no-reflow phenomenon increased risk of operation and mortality.
Enhance the knowledge of no-reflow and coped with it timely in right way should improved coronary flow and prognosis of patients.
Related Results
Cardio protective effect of nicorandil in reperfusion injury among patients undergoing primary percutaneous coronary intervention
Cardio protective effect of nicorandil in reperfusion injury among patients undergoing primary percutaneous coronary intervention
Objectives: To evaluate the effect of nicorandil in prevention of reperfusion injury during primary percutaneous coronary intervention by thrombolysis in myocardial infarction flow...
Cardiac Rehabilitation Improves Long-Term Prognosis for People with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: A Propensity Matching Analysis
Cardiac Rehabilitation Improves Long-Term Prognosis for People with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: A Propensity Matching Analysis
Objectives. According to researches, many people with chronic kidney disease (CKD) had the higher incidence rate and mortality rate of coronary artery disease (CAD) after percutane...
Mortality predictors in patients with ST-segment elevation myocardial infarction presenting no-reflow phenomenon after primary PCI: experience of a tertiary center
Mortality predictors in patients with ST-segment elevation myocardial infarction presenting no-reflow phenomenon after primary PCI: experience of a tertiary center
Abstract
The mortality rate in subjects with ST-segment elevation acute myocardial infarction (STEMI) is increased because of short- and long-term complications.
...
Pengalaman Pasien ACS (Acute Coronary Syndrome) yang Menjalani PCI (Percutaneous Coronary Intervention)
Pengalaman Pasien ACS (Acute Coronary Syndrome) yang Menjalani PCI (Percutaneous Coronary Intervention)
Background: Cardiovascular disease is one of the non-communicable diseases that has a high prevalence in the world. According to WHO (World Health Organization), data the highest ...
Clinical characteristics and in - hospital outcome of acute coronary syndrome in patients with three - vessel and/ or left main coronary artery disease after percutaneous coronary intervention
Clinical characteristics and in - hospital outcome of acute coronary syndrome in patients with three - vessel and/ or left main coronary artery disease after percutaneous coronary intervention
Background: Many studies in Vietnam have shown that there is an increasing number of patients hospitalized due to acute coronary syndrome (ACS) with multivessel stenosis and/or wit...
e0543 Clinical and coronary angiography characteristics between young (<45) and old (>60) patients with coronary artery disease
e0543 Clinical and coronary angiography characteristics between young (<45) and old (>60) patients with coronary artery disease
Objective
To study the clinical Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease.
...
e0425 Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease
e0425 Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease
Objective
To study the clinical Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease.
...
Ostial Right Coronary Artery Stent Loss, Stent-In-Stent Entrapment, and Subsequent Surgical Extraction
Ostial Right Coronary Artery Stent Loss, Stent-In-Stent Entrapment, and Subsequent Surgical Extraction
Abstract
Background:
Percutaneous coronary intervention of calcified coronary lesions is fraught with short-term and long-term risks. Judicious use of adjunct intracoronary...

